Sophocarpine Suppresses NF-κB-Mediated Inflammation Both In Vitro and In Vivo and Inhibits Diabetic Cardiomyopathy

Diabetic cardiomyopathy (DCM) is a leading cause of mortality in patients with diabetes. DCM is a leading cause of mortality in patients with diabetes. We used both in vitro and in vivo experiments to investigate the hypothesis that sophocarpine (SPC), a natural quinolizidine alkaloid derived from...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Fang Zou, Ling Wang, Han Liu, Wei Wang, Longlong Hu, Xiaoying Xiong, Lijuan Wu, Yunfeng Shen, Renqiang Yang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2019-10-01
Sarja:	Frontiers in Pharmacology
Aiheet:	sophocarpine NF-κB inflammation diabetes cardiomyopathy—diagnostics
Linkit:	https://www.frontiersin.org/article/10.3389/fphar.2019.01219/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!